Helius Medical Technologies Inc [NASDAQ: HSDT] gained 7.64% or 0.68 points to close at $9.58 with a heavy trading volume of 18002043 shares.
It opened the trading session at $13.81, the shares rose to $14.45 and dropped to $9.21, the range by which the price of stock traded the whole day. The daily chart for HSDT points out that the company has recorded -98.41% loss over the past six months.
If we look at the average trading volume of 150.35K shares, HSDT reached to a volume of 18002043 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here is what top equities market gurus are saying about Helius Medical Technologies Inc [HSDT]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for HSDT shares is $3000.00 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on HSDT stock is a recommendation set at 1.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Noble Capital Markets have made an estimate for Helius Medical Technologies Inc shares, keeping their opinion on the stock as Outperform, with their previous recommendation back on March 24, 2021.
The Price to Book ratio for the last quarter was 0.06, with the Price to Cash per share for the same quarter was set at 1.64.
Trading performance analysis for HSDT stock
Helius Medical Technologies Inc [HSDT] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 30.34. With this latest performance, HSDT shares dropped by -46.82% in over the last four-week period, additionally sinking by -98.41% over the last 6 months – not to mention a drop of -98.09% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for HSDT stock in for the last two-week period is set at 24.37, with the RSI for the last a single of trading hit 3.35, and the three-weeks RSI is set at 9.71 for Helius Medical Technologies Inc [HSDT]. The present Moving Average for the last 50 days of trading for this stock 89.09, while it was recorded at 8.59 for the last single week of trading, and 313.03 for the last 200 days.
Helius Medical Technologies Inc [HSDT]: A deeper dive into fundamental analysis
Operating Margin for any stock indicates how profitable investing would be, and Helius Medical Technologies Inc [HSDT] shares currently have an operating margin of -3331.34% and a Gross Margin at -39.40%. Helius Medical Technologies Inc’s Net Margin is presently recorded at -3010.14%.
Helius Medical Technologies Inc (HSDT) Capital Structure & Debt Analysis
According to recent financial data for Helius Medical Technologies Inc. ( HSDT), the Return on Equity (ROE) stands at -800.00%, highlighting a negative impact on investor capital. The Return on Assets (ROA) is -282.74%, reflecting the company’s efficiency in generating profits from its assets. Additionally, Helius Medical Technologies Inc’s Return on Invested Capital (ROIC) is -1020.63%, showcasing its effectiveness in deploying capital for earnings.
Helius Medical Technologies Inc (HSDT) Efficiency & Liquidity Metrics
Based on Helius Medical Technologies Inc’s (HSDT) latest financial statements, the Debt-to-Equity Ratio is 0.00%, indicating its reliance on debt financing relative to shareholder equity.
Helius Medical Technologies Inc (HSDT) Efficiency & Liquidity Metrics
From an operational efficiency perspective, Helius Medical Technologies Inc. (HSDT) effectively leverages its workforce, generating an average of -$621904.76 per employee. The company’s liquidity position is robust, with a Current Ratio of 1.69% and a Quick Ratio of 1.13%, indicating strong ability to cover short-term liabilities.
An analysis of Institutional ownership at Helius Medical Technologies Inc [HSDT]
There are presently around $6.31%, or 7.67%% of HSDT stock, in the hands of institutional investors.
